Recursion Pharmaceuticals, Inc.

Q3 2022 13F Holders

Symbol
RXRX
CUSIP
75629V104
Type
Equity
Class
CL A
Num filers
147
Total reported value, excl. options
$1.21B
Manager Report Date Value ($000) Shares Option Type